10902790

Asunci?n M

2000

A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

10902801

McDonald C

2000

Minimal-model estimates of insulin sensitivity are insensitive to errors in glucose effectiveness.

10923276

Atiomo WU

2000

Immunohistochemical detection of plasminogen activator inhibitor-1 in polycystic ovaries.

10923277

Panidis DK

2000

The influence of long-term administration of conjugated estrogens and antiandrogens to serum leptin levels in women with polycystic ovary syndrome.

10927062

Zullo F

2000

Minilaparoscopic ovarian drilling under local anesthesia in patients with polycystic ovary syndrome.

10927066

Glueck CJ

2000

Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage.

10927079

Daya S

2000

The challenge of meta-analysis and the need to register clinical trials.

10929964

Douchi T

2000

The effects of gonadotropin-releasing hormone agonist on body composition in a patient with polycystic ovary syndrome.

10940617

Bauer J

2000

Polycystic ovary syndrome in patients with focal epilepsy: a study in 93 women.

10941427

De Nuccio I

1999

Physiopathology of the renin-angiotensin system in the ovary.

10941495

Duflos-Cohade C

2000

[Menstrual cycle disorders in adolescents].

10943580

Zafeiriou S

2000

The role of gonadotropins in follicular development and their use in ovulation induction protocols for assisted reproduction.

10946879

Pasquali R

2000

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

10948623

Dukovski A

2000

[Polycystic ovaries--their ultrasonic diagnosis].

10948625

Nikolov A

2000

[Myoma uteri per magna developing in a girl of 15].

10951152

Cibula D

2000

The role of androgens in determining acne severity in adult women.

10958005

Taylor AE

2000

Insulin-lowering medications in polycystic ovary syndrome.

10963873

Franks S

2000

Follicular dynamics in the polycystic ovary syndrome.

10966981

Cataldo NA

2000

Immunolocalization of Fas and Fas ligand in the ovaries of women with polycystic ovary syndrome: relationship to apoptosis.

10968340

Check JH

2000

Ovarian hyperstimulation can reduce uterine receptivity. A case report.

10972519

Ron-El R

2000

Induction of ovulation after gnRH antagonists.

10973653

Loucks TL

2000

Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?

10973656

Wu X

2000

Expression of insulin-receptor substrate-1 and -2 in ovaries from women with insulin resistance and from controls.

10973659

Tulandi T

2000

Effects of laparoscopic ovarian drilling on serum vascular endothelial growth factor and on insulin responses to the oral glucose tolerance test in women with polycystic ovary syndrome.

10976414

Genazzani AD

2000

The use of a combined regimen of GnRH agonist plus a low-dose oral contraceptive improves the spontaneous pulsatile LH secretory characteristics in patients with polycycstic ovary disease after discontinuation of treatment.

10985619

Yarali H

2000

Combined bilateral ectopic and intrauterine pregnancy following ovulation induction with the low-dose step-up protocol in a patient with polycystic ovary syndrome.

10987057

Jaffiol C

1999

[Insulin resistance: from clinical diagnosis to molecular genetics. Implications in diabetes mellitus].

10992177

Bornstein J

2000

Increased endometrial thickness in women with hypertension.

10994635

Deshpande RR

2000

Alteration of cytokine production in follicular cystic ovaries induced in mice by neonatal estradiol injection.

10996697

Atiomo WU

2000

Ultrasound criteria in the diagnosis of polycystic ovary syndrome (PCOS).

10997532

Hunter MH

2000

Polycystic ovary syndrome: it's not just infertility.

10997613

Nestler JE

2000

Obesity, insulin, sex steroids and ovulation.

10999803

Morin-Papunen LC

2000

Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.

10999817

Ib??ez L

2000

Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide.

10999852

Mifsud A

2000

Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries.

11005272

Bartolone L

2000

Extremely high levels of estradiol and testosterone in a case of polycystic ovarian syndrome. Hormone and clinical similarities with the phenotype of the alpha estrogen receptor null mice.

11006180

Gennarelli G

2000

Prediction models for insulin resistance in the polycystic ovary syndrome.

11006314

Oksanen L

2000

No evidence for mutations of the leptin or leptin receptor genes in women with polycystic ovary syndrome.

11006648

Qui??nez Zarza C

2000

[Obesity, arterial hypertension, metabolic disorders, and polycystic ovary syndrome].

11008348

Maliqueo M

2000

[Evaluation of acute effect of GnRH administration on leptin secretion in normal and hyperandrogenic women].

11012575

Kaltsas GA

2000

How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?

11012576

Kousta E

2000

The prevalence of polycystic ovaries in women with a history of gestational diabetes.

11014193

Burks DJ

2000

IRS-2 pathways integrate female reproduction and energy homeostasis.

11014952

Ohata Y

2000

Coasting may reduce the severity of the ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome.

11020518

Lidor AL

2000

Management of women with polycystic ovary syndrome who experienced premature luteinization during clomiphene citrate treatment.

11020522

Tuckerman EM

2000

Do androgens have a direct effect on endometrial function? An in vitro study.

11022181

Wu XK

2000

Ovarian-adrenal cross-talk in polycystic ovary syndrome: evidence from wedge resection.

11022191

Asteria C

2000

Identification of follistatin as a possible trait-causing gene in polycystic ovary syndrome.

11026085

Simon-Vermot I

2000

[Consequences and complications of obesity].

11030301

Lakhani K

2000

Internal carotid-artery response to 5% carbon dioxide in women with polycystic ovaries.

11030311

Jeffcoate W

2000

Diab?te des femmes ? barbe: a classic paper reread.

11033690

Tweedy A

2000

Polycystic ovary syndrome.

11034687

Nugent D

2000

Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.

11038778

Wang A

1998

[The effects of FSH,LH and insulin on steroids production by granulosa cells from polycystic ovaries syndrome].

11039233

Podrouzek P

2000

[Polycystic ovary syndrome as a multisystemic endocrinopathy].

11042934

Rogers D

2000

Key developments in endocrinology.

11045880

Fowler DJ

2000

Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract.

11056123

de Leo V

2000

Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome.

11056243

Takebayashi K

2000

Mutation analysis of the growth differentiation factor-9 and -9B genes in patients with premature ovarian failure and polycystic ovary syndrome.

11058557

Stener-Victorin E

2000

Effects of electro-acupuncture on nerve growth factor and ovarian morphology in rats with experimentally induced polycystic ovaries.

11059764

Habuchi T

2000

Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.

11061489

Zborowski JV

2000

Clinical Review 116: Bone mineral density, androgens, and the polycystic ovary: the complex and controversial issue of androgenic influence in female bone.

11061494

Oberfield SE

2000

Metabolic lessons from the study of young adolescents with polycystic ovary syndrome--is insulin, indeed, the culprit?

11061495

Ib??ez L

2000

Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche.

11073846

Talbott EO

2000

Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women.

11082960

Grzechoci?ska B

2000

[Results of clomiphene citrate ovarian stimulation vs laparoscopic electrocoagulation of the ovaries in infertile women with PCOS].

11082961

Grzonka D

2000

[Comparison of conservative and laparoscopic treatment of PCOS].

11082975

Kuczy?ski W

2000

[Prolonged desensitization pretreatment for in vitro fertilization in women with polycystic ovary].

11083066

Vrb?klov? J

2000

An analysis of the relationship between insulin resistance and the activity of steroid C17,20-lyase and 3beta-hydroxysteroid dehydrogenase in ovaries and adrenals in women with polycystic ovary syndrome.

11091985

Jensen JT

2000

Health benefits of oral contraceptives.

11092704

Takahashi K

2000

A case of a pregnant woman with luteal insufficiency and a mutation in the beta-subunit of luteinizing hormone.

11095431

Eagleson CA

2000

Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.

11095451

Escobar-Morreale HF

2000

High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus.

11095477

Martens JW

2000

Enzymatic activities of P450c17 stably expressed in fibroblasts from patients with the polycystic ovary syndrome.

11098013

Teissier MP

2000

Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundability.

11098021

Muenstermann U

2000

Long-term GnRH analogue treatment is equivalent to laparoscopic laser diathermy in polycystic ovarian syndrome patients with severe ovarian dysfunction.

11108294

Chi MM

2000

High insulin-like growth factor 1 (IGF-1) and insulin concentrations trigger apoptosis in the mouse blastocyst via down-regulation of the IGF-1 receptor.

11109312

Bidzi?ska B

2000

Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.

11109972

Fedorcs?k P

2000

Impaired insulin action on granulosa-lutein cells in women with polycystic ovary syndrome and insulin resistance.

11109973

Szil?gyi A

2000

Hormonal and clinical effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.

11109980

Scarpitta AM

2000

Polycystic ovary syndrome: an endocrine and metabolic disease.

11116614

L?vy D

2000

[Secondary amenorrhea. Diagnostic approach].

11117667

DiMartino-Nardi J

2000

Pre- and postpuberal findings in premature adrenarche.

11117669

Pugeat M

2000

Sex hormone-binding globulin during puberty in normal and hyperandrogenic girls.

11117670

Taylor AE

2000

The gonadotropic axis in hyperandrogenic adolescents.

11117671

Rosenfield RL

2000

Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism.

11117672

Ciaraldi TP

2000

Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity.

11117673

Nestler JE

2000

Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome.

11117674

Ehrmann DA

2000

Glucose intolerance in the polycystic ovary syndrome: role of the pancreatic beta-cell.

11117675

Azziz R

2000

Family history as a risk factor for the polycystic ovary syndrome.

11117676

Legro RS

2000

Is there a male phenotype in polycystic ovary syndrome families?

11117677

Urbanek M

2000

Searching for the polycystic ovary syndrome genes.

11117678

Witchel SF

2000

The role of heterozygosity for CYP21 in the polycystic ovary syndrome.

11117758

Kelly CJ

2000

The long term health consequences of polycystic ovary syndrome.

11119744

Vel?zquez M E

2000

Postprandial triglyceride response in patients with polycystic ovary syndrome: relationship with waist-to-hip ratio and insulin.

11119756

Atiomo WU

2000

Are women with polycystic ovary syndrome resistant to activated protein C?

11119757

Tong Y

2000

Association of AccI polymorphism in the follicle-stimulating hormone beta gene with polycystic ovary syndrome.

11119758

Kahsar-Miller M

2000

A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome.

11120504

Barbieri RL

2000

Induction of ovulation in infertile women with hyperandrogenism and insulin resistance.

11126652

Di Maio S

2000

[Hirsutism and hypertrichosis].